Healio4d
Oral vancomycin may offer ‘viable option’ for IBD-related primary sclerosing cholangitis
Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...
Health.com23d
What To Know About Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC. The symptoms of PSC ...
Chemomab completes End-of-Phase 2 Meeting with the FDA for CM-101
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
Chemomab Therapeutics price target raised to $7 from $4 at Maxim
Maxim raised the firm’s price target on Chemomab Therapeutics (CMMB) to $7 from $4 and keeps a Buy rating on the shares. The firm cites the ...
Common antibiotic for diarrhoea shows hope for inflammatory bowel disease: Study
The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...
News Medical on MSN9d
Oral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shifts
In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...
BMJ18d
What are the lived healthcare experiences of patients with primary sclerosing cholangitis? A community-based qualitative interview study
Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and clinicians. This study aimed to explore the experiences of patients with PSC ...
birmingham.ac.uk12d
Common antibiotic could treat inflammatory bowel disease, new study finds
Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...